FGF2 cooperates with IL-17 to promote autoimmune inflammation

Xinrui Shao,Siyuan Chen,Daping Yang,Mengtao Cao,Yikun Yao,Zhengxi Wu,Ningli Li,Nan Shen,Xiaoxia Li,Xinyang Song,Youcun Qian
DOI: https://doi.org/10.1038/s41598-017-07597-8
IF: 4.6
2017-01-01
Scientific Reports
Abstract:IL-17 is a pro-inflammatory cytokine implicated a variety of autoimmune diseases. We have recently reported that FGF2 cooperates with IL-17 to protect intestinal epithelium during dextran sodium sulfate (DSS)-induced colitis. Here, we report a pathogenic role of the FGF2-IL-17 cooperation in the pathogenesis of autoimmune arthritis. Combined treatment with FGF2 and IL-17 synergistically induced ERK activation as well as the production of cytokines and chemokines in human synovial intimal resident fibroblast-like synoviocytes (FLS). Furthermore, ectopic expression of FGF2 in mouse joints potentiated IL-17-induced inflammatory cytokine and chemokine production in the tissue. In the collagen-induced arthritis (CIA) model, while ectopic expression of FGF2 in vivo exacerbated tissue inflammation and disease symptom in the wild-type controls, the effect was largely blunted in Il17a −/− mice. Taken together, our study suggests that FGF2 cooperates with IL-17 to promote the pathogenesis of autoimmune arthritis by cooperating with IL-17 to induce inflammatory response.
What problem does this paper attempt to address?